AMICAS approved to repurchase shares

AMICAS Inc. has announced that its Board of Directors has approved the repurchase of as much as $15 million of the Company's common stock from the open market or privately negotiated transactions as needed, AMICAS said.
   
The schedule for such repurchases will be determined by the company's management. The transactions can also be made under a Rule 10b5-1 plan, which allows shares to be bought back in instances where company is otherwise not permitted to do so under insider trading laws.

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.